Overactive bladder-18 years - Part I

Overactive bladder-18 years - Part I

Author Truzzi, Jose Carlos Autor UNIFESP Google Scholar
Gomes, Cristiano Mendes Google Scholar
Bezerra, Carlos A. Google Scholar
Plata, Ivan Mauricio Google Scholar
Campos, Jose Google Scholar
Garrido, Gustavo Luis Google Scholar
Almeida, Fernando G. Autor UNIFESP Google Scholar
Averbeck, Marcio Augusto Google Scholar
Fornari, Alexandre Google Scholar
Salazar, Anibal Google Scholar
Dell'Oro, Arturo Google Scholar
Cintra, Caio Google Scholar
Ricetto Sacomani, Carlos Alberto Google Scholar
Tapia, Juan Pablo Google Scholar
Brambila, Eduardo Google Scholar
Longo, Emilio Miguel Google Scholar
Rocha, Flavio Trigo Google Scholar
Coutinho, Francisco Google Scholar
Favre, Gabriel Google Scholar
Garcia, Jose Antonio Google Scholar
Castano, Juan Google Scholar
Reyes, Miguel Google Scholar
Leyton, Rodrigo Eugenio Google Scholar
Ferreira, Ruiter Silva Google Scholar
Duran, Sergio Google Scholar
Lopez, Vanda Google Scholar
Reges, Ricardo Google Scholar
Abstract Overactive bladder syndrome is one of the lower urinary tract dysfunctions with the highest number of scientific publications over the past two decades. This shows the growing interest in better understanding this syndrome, which gathers symptoms of urinary urgency and increased daytime and nighttime voiding frequency, with or without urinary incontinence and results in a negative impact on the quality of life of approximately one out of six individuals - including both genders and almost all age groups. The possibility of establishing the diagnosis just from clinical data made patients' access to specialized care easier. Physiotherapy resources have been incorporated into the urological daily practice. A number of more selective antimuscarinic drugs with consequent lower adverse event rates were released. Recently, a new class of oral drugs, beta-adrenergic agonists has become part of the armamentarium for Overactive Bladder. Botulinum toxin injections in the bladder and sacral neuromodulation are routine modalities of treatment for refractory cases. During the 1st Latin-American Consultation on Overactive Bladder, a comprehensive review of the literature related to the evolution of the concept, epidemiology, diagnosis, and management was conducted. This text corresponds to the first part of the review Overactive Bladder 18-years.
Keywords Overactive Bladder
Muscarinic Antagonists
Beta-adrenergic agonists
Botulinum Toxin
Sacral neuromodulation
xmlui.dri2xhtml.METS-1.0.item-coverage Rio De Janeiro
Language English
Date 2016
Published in International Braz J Urol. Rio De Janeiro, v. 42, n. 2, p. 188-198, 2016.
ISSN 1677-5538 (Sherpa/Romeo, impact factor)
Publisher Brazilian Soc Urol
Extent 188-198
Origin http://dx.doi.org/10.1590/S1677-5538.IBJU.2015.0365
Access rights Open access Open Access
Type Article
Web of Science ID WOS:000375604900005
SciELO ID S1677-55382016000200188 (statistics in SciELO)
URI https://repositorio.unifesp.br/handle/11600/57828

Show full item record


Name: S1677-55382016000200188-en.pdf
Size: 110.5Kb
Format: PDF
Open file

This item appears in the following Collection(s)




My Account